CI

At a glance

ClinicalIndex Comparison Record
Phase 2Recruiting· 100 target
Drug / intervention
Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06756074
NCT06756074Phase 2RecruitingMonitorUpdated 3mo ago · Completion was 2mo ago
Slow Enrollment
Monitor

Impact of Reinforced Pancreaticojejunostomy With or Without Tissue Adhesive Glue Modified Cyanoacrylate (Glubran 2) Following Pancreaticoduodenectomy, Randomized Controlled Clinical Trial.

Minia University·interventional·Posted Jan 1, 2025·Updated Mar 16, 2026

In Brief

A Phase 2 clinical trial evaluating Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2) and Pancreaticojejunostomy without tissue adhesive glue modified cyanoacrylate (glubran 2) for Pancreatic Fistula and 3 related conditions. Currently recruiting, targeting 100 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

Phase 2RecruitingOverdue
20252026
First PostedJan 1, 2025
Enrollment StartJan 15, 2025
Primary CompletionApr 15, 2026
Study CompletionMay 15, 2026
TodayJul 1, 2026
Enrollment to primary: 1.3 yearsPosted 1.5 years ago

Interventions

Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2)drug

pancreaticojejunostomy was done with application of glubran 2: The blister pack was opened, and the sterile single-dose vial was released directly onto the operating table in a sterile environment, Draw the Glubran 2 out of the single-dose vial using a sterile syringe then put the syringe into applicator Glubran 2 was applied into anastomosis by applicator in spraying manner . Whenever possible, the area to be treated should be cleaned before application. When applied in such a minimal amount, once it had polymerized, Glubran 2 formed a thin adhesive layer. It was therefore essential not to apply more than one drop in the same point. A second layer of Glubran 2 may not be applied until the first had polymerized. Any excess product was removed using a dry swab within 5-6 seconds after application. Glubran 2 was not touched after application until the polymerization reaction is complete, as it may detach or not produce the desired effect.

Pancreaticojejunostomy without tissue adhesive glue modified cyanoacrylate (glubran 2)procedure

Pancreaticojejunostomy without tissue adhesive glue modified cyanoacrylate (glubran 2)